Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
This study has been completed.
Sponsor:
Collaborator:
Cancer and Leukemia Group B
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00052949
First received: January 24, 2003
Last updated: December 4, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | July 2004 (Final data collection date for primary outcome measure) |